3.8723
1.47%
-0.0577
After Hours:
3.8723
Clever Leaves Holdings Inc stock is currently priced at $3.8723, with a 24-hour trading volume of 4,121.
It has seen a -1.47% decreased in the last 24 hours and a -13.18% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $4.02 pivot point. If it approaches the $3.81 support level, significant changes may occur.
Previous Close:
$3.93
Open:
$3.85
24h Volume:
4,121
Market Cap:
$6.80M
Revenue:
$18.57M
Net Income/Loss:
$-41.63M
P/E Ratio:
-0.0956
EPS:
-40.5
Net Cash Flow:
$-14.70M
1W Performance:
-5.44%
1M Performance:
-13.18%
6M Performance:
+60.01%
1Y Performance:
+1,149%
Clever Leaves Holdings Inc Stock (CLVR) Company Profile
Name
Clever Leaves Holdings Inc
Sector
Phone
561 634 7430
Address
6501 Congress Avenue, Suite 240, Boca Raton
Clever Leaves Holdings Inc Stock (CLVR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-27-21 | Initiated | Canaccord Genuity | Buy |
Jul-23-21 | Initiated | Cowen | Market Perform |
Clever Leaves Holdings Inc Stock (CLVR) Latest News
Clever Leaves Holdings Inc Stock (CLVR) Financials Data
Clever Leaves Holdings Inc (CLVR) Revenue 2024
CLVR reported a revenue (TTM) of $18.57 million for the quarter ending September 30, 2023, a +14.62% rise year-over-year.
Clever Leaves Holdings Inc (CLVR) Net Income 2024
CLVR net income (TTM) was -$41.63 million for the quarter ending September 30, 2023, a +32.14% increase year-over-year.
Clever Leaves Holdings Inc (CLVR) Cash Flow 2024
CLVR recorded a free cash flow (TTM) of -$14.70 million for the quarter ending September 30, 2023, a +58.24% increase year-over-year.
Clever Leaves Holdings Inc (CLVR) Earnings per Share 2024
CLVR earnings per share (TTM) was -$29.36 for the quarter ending September 30, 2023, a +51.50% growth year-over-year.
About Clever Leaves Holdings Inc
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Cap:
|
Volume (24h):